ABOUT US

Broadway DNA is an Independent Theatrical IP & International Deal Architecture Firm connecting emerging theatremakers to global markets.

What We Do

Broadway DNA helps emerging musicals and international theatre projects reach global audiences. We structure rights, co-productions, foreign licensing, and U.S. market entry strategies — turning creative ideas into scalable, internationally viable productions that connect artists with audiences worldwide.

Select Services

  • Bespoke new work development & world premieres with global rollout strategy

  • Multi-Territory Slate Deals

  • Individualized licensing strategy beyond catalog licensing

  • Investor + government fund + partner matchmaking

  • U.S. Market Entry & Touring Strategy for International Productions

  • Multi-author, studio, and collaborator rights chain cleanup and packaging

  • International capitalization structures

  • Early Territory Optioning

  • Territory Premiere & First-Entry Licensing Packages

  • Local-Language Adaptation + Co-Production Packaging

  • Workshop / Lab / Residency Export Partnerships

Exists

✔ Broadway transfer producers

✔ Commercial touring networks (for proven Broadway shows)

✔ Festival invites (one-off runs, not scalable touring)

✔ Independent booking agents (relationship-driven, not strategic)

The Broadway DNA Difference

🧬 Development-to-tour pipelines for domestic & foreign work

🧬 Market entry strategy for mid-scale international shows

🧬 IP-aware development, premiere, and touring (rights, licensing, remounts, capture, etc.)

🧬 Bespoke hybrid nonprofit + commercial distribution structures

Who We Work With

  • Emerging & Mid-Tier Artists & Producers Expanding Overseas

  • Foreign Producers Wanting to Import U.S. I.P.

  • Foreign Producers Trying to Export I.P. into the U.S.

  • Catalog Owners Without International Strategy Depth

  • Government / Cultural Investment Entities

  • International Festivals & Cultural Platforms Scaling Commercially